June 2014 - Volume 34 - Issue 3
pp: 291-420,e1-e3
Subscribe to eTOC



Treatment Outcomes of Depression: The Pharmacogenomic Research Network Antidepressant Medication Pharmacogenomic Study

Mrazek, David A.; Biernacka, Joanna M.; McAlpine, Donald E.; More

Journal of Clinical Psychopharmacology . 34(3):313-317, June 2014.

Plasma Fluoxetine Concentrations and Clinical Improvement in an Adolescent Sample Diagnosed With Major Depressive Disorder, Obsessive-Compulsive Disorder, or Generalized Anxiety...

Blázquez, Ana; Mas, Sergi; Plana, Maria Teresa; More

Journal of Clinical Psychopharmacology . 34(3):318-326, June 2014.

Hepatotoxicity Related to Agomelatine and Other New Antidepressants: A Case/Noncase Approach With Information From the Portuguese, French, Spanish, and Italian Pharmacovigilance...

Montastruc, François; Scotto, Stefania; Vaz, Ines Ribeiro; More

Journal of Clinical Psychopharmacology . 34(3):327-330, June 2014.

SLC17A7 Gene May Be the Indicator of Selective Serotonin Reuptake Inhibitor Treatment Response in the Chinese Han Population

Li, Xin; Yu, Tao; Huang, Xiaoye; More

Journal of Clinical Psychopharmacology . 34(3):331-336, June 2014.

The Effects of Add-On Low-Dose Memantine on Cytokine Levels in Bipolar II Depression: A 12-Week Double-Blind, Randomized Controlled Trial

Lee, Sheng-Yu; Chen, Shiou-Lan; Chang, Yun-Hsuan; More

Journal of Clinical Psychopharmacology . 34(3):337-343, June 2014.